Birmingham Women’s and Children’s NHS Foundation Trust
256 capabilities
Verified Aug 2026
One of 2,380 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Microbiology Department, Birmingham Children’s Hospital, Steelhouse Lane
Birmingham B4 6NH , United Kingdom
Birmingham B4 6NH , United Kingdom
Accreditation
Active
UKAS
9896
nhs.net
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
9896
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Test Capabilities (256)
| Standard Reference | Description | Category |
|---|---|---|
| 1. | Fibrinogen | 1. | Fibrinogen | Clinical Chemistry |
| Citrated plasma | - PT, INR Werfen ACL TOP 350 | Citrated plasma | - PT, INR Werfen ACL TOP 350 | Clinical Chemistry |
| LMWH Anti Xa assay | Werfen ACL TOP 350 | LMWH Anti Xa assay | Werfen ACL TOP 350 | Clinical Chemistry |
| Lupus anticoagulant screen and | Werfen ACL TOP 350 | Lupus anticoagulant screen and | Werfen ACL TOP 350 | Clinical Chemistry |
| Volume | SOP CP68235 - Initial | Volume | SOP CP68235 - Initial | Clinical Chemistry |
| Volume | Semen Sample | Volume | Semen Sample | Clinical Chemistry |
| Volume | Volume/weight using EK-200i | Volume | Volume/weight using EK-200i | Clinical Chemistry |
| Detection of sperm | (Andrology 2276) | Detection of sperm | (Andrology 2276) | Clinical Microbiology |
| SARS-CoV spike and SARS-CoV-2 | SARS-CoV-2 | SARS-CoV spike and SARS-CoV-2 | SARS-CoV-2 | Clinical Microbiology |
| Sperm concentration | SOP 2403 - Evaluation of Sperm | Sperm concentration | SOP 2403 - Evaluation of Sperm | Clinical Microbiology |
| Sperm morphology including TZI | SOP 2307 - Sperm Morphology | Sperm morphology including TZI | SOP 2307 - Sperm Morphology | Clinical Microbiology |
| Sperm motility | Motility | Sperm motility | Motility | Clinical Microbiology |
| Sperm motility | SOP 2402 - Evaluation of Sperm | Sperm motility | SOP 2402 - Evaluation of Sperm | Clinical Microbiology |
| Sperm vitality | SOP 2404 - Evaluation of Sperm | Sperm vitality | SOP 2404 - Evaluation of Sperm | Clinical Microbiology |
| Sperm vitality | Vitality | Sperm vitality | Vitality | Clinical Microbiology |
| - Duffy (Fya Fyb); | SOP1565: ABO/ D group | - Duffy (Fya Fyb); | SOP1565: ABO/ D group | Hematology |
| - Kidd (Jka Jkb); | SOP 41: Antibody Identification | - Kidd (Jka Jkb); | SOP 41: Antibody Identification | Hematology |
| - MNS (M N S s); | SOP 1410: 4 Cell D negative | - MNS (M N S s); | SOP 1410: 4 Cell D negative | Hematology |
| AB Rh D Negative | SOP1565: ABO/ D group | AB Rh D Negative | SOP1565: ABO/ D group | Hematology |
| Blood Full Blood Count (FBC) analysis of the | Sysmex XN-2000 | Blood Full Blood Count (FBC) analysis of the | Sysmex XN-2000 | Hematology |
| Blood Glucose 6 Phosphate Dehydrogenase | G6PDH Deficiency | Blood Glucose 6 Phosphate Dehydrogenase | G6PDH Deficiency | Hematology |
| Blood Glucose 6 Phosphate Dehydrogenase | SOP: 59 G6PD screening test | Blood Glucose 6 Phosphate Dehydrogenase | SOP: 59 G6PD screening test | Hematology |
| Blood Haemoglobinopathy screening | Capilliarys2 Flex piercing | Blood Haemoglobinopathy screening | Capilliarys2 Flex piercing | Hematology |
| Blood Haemoglobinopathy screening | SEBIA Capillarys 2 Flex | Blood Haemoglobinopathy screening | SEBIA Capillarys 2 Flex | Hematology |
| Blood Haemoglobinopathy screening | SOP: 79A Capilliary Iso-electric | Blood Haemoglobinopathy screening | SOP: 79A Capilliary Iso-electric | Hematology |
| Bone Marrow | Blood kit | Bone Marrow | Blood kit | Hematology |
| Bone Marrow | PP 03.01.65 | Bone Marrow | PP 03.01.65 | Hematology |
| Bone Marrow | PP.03.01.66 | Bone Marrow | PP.03.01.66 | Hematology |
| C E c e K | SOP 1279: Red Cell Phenotyping | C E c e K | SOP 1279: Red Cell Phenotyping | Hematology |
| EDTA Plasma Compatibility testing of patients’ | SOP 28: Compatibility Testing | EDTA Plasma Compatibility testing of patients’ | SOP 28: Compatibility Testing | Hematology |
| EDTA Red Cells Antigen Phenotyping: | IBG Immucor NEO Iris Analyser | EDTA Red Cells Antigen Phenotyping: | IBG Immucor NEO Iris Analyser | Hematology |
| Foetal Blood | PP 03.01.24 | Foetal Blood | PP 03.01.24 | Hematology |
| Peripheral Blood | PP 03.01.12 | Peripheral Blood | PP 03.01.12 | Hematology |
| Quantitative assessment of volume by | SOP 24: The Kleihauer Test | Quantitative assessment of volume by | SOP 24: The Kleihauer Test | Hematology |
| RBC | Sysmex XN-2000 analysers | RBC | Sysmex XN-2000 analysers | Hematology |
| following parameters: | SOP: Haematology 2222 – FBC | following parameters: | SOP: Haematology 2222 – FBC | Hematology |
| 10% Neutral Buffered Formalin Identification of cellular or tissue | Bond Autostainer - SOP 924 | 10% Neutral Buffered Formalin Identification of cellular or tissue | Bond Autostainer - SOP 924 | Histopathology / Cytology |
| 10% Neutral Buffered Formalin Identification of cellular or tissue | Documented In-house Methods | 10% Neutral Buffered Formalin Identification of cellular or tissue | Documented In-house Methods | Histopathology / Cytology |
| 10% Neutral Buffered Formalin Identification of nuclei, cell cytoplasm | Documented In-house Methods | 10% Neutral Buffered Formalin Identification of nuclei, cell cytoplasm | Documented In-house Methods | Histopathology / Cytology |
| 10% Neutral Buffered Formalin Identification of nuclei, cell cytoplasm | Leica HistoCore Spectra Stainer | 10% Neutral Buffered Formalin Identification of nuclei, cell cytoplasm | Leica HistoCore Spectra Stainer | Histopathology / Cytology |
| 10% Neutral Buffered Formalin Identification of nuclei, cell cytoplasm | Routine H&E Staining Using the | 10% Neutral Buffered Formalin Identification of nuclei, cell cytoplasm | Routine H&E Staining Using the | Histopathology / Cytology |
| 10% Neutral Buffered Formalin Identification of nuclei, cell cytoplasm | – SOP 68295 | 10% Neutral Buffered Formalin Identification of nuclei, cell cytoplasm | – SOP 68295 | Histopathology / Cytology |
| Acid mucins | Acid Mucin - SOP 68352 | Acid mucins | Acid Mucin - SOP 68352 | Histopathology / Cytology |
| Adenocarcinoma – ovarian vs | CA125 | Adenocarcinoma – ovarian vs | CA125 | Histopathology / Cytology |
| Adenocarcinoma, squamous cell | CAM5.2 | Adenocarcinoma, squamous cell | CAM5.2 | Histopathology / Cytology |
| Amniotic fluid tumours and companion testing | Manual Process PP 02.01.40 | Amniotic fluid tumours and companion testing | Manual Process PP 02.01.40 | Histopathology / Cytology |
| Breast carcinoma and metastatic | GCDFP-15 | Breast carcinoma and metastatic | GCDFP-15 | Histopathology / Cytology |
| Clear cell carcinoma | Napsin | Clear cell carcinoma | Napsin | Histopathology / Cytology |
| Collagen, fibrin & muscle | 68365 | Collagen, fibrin & muscle | 68365 | Histopathology / Cytology |
| Developmental Disorders | Cell Harvesting | Developmental Disorders | Cell Harvesting | Histopathology / Cytology |
| Differentiation between benign and | Glypican 3 | Differentiation between benign and | Glypican 3 | Histopathology / Cytology |
| Elastic fibres, collagen & muscle | SOP 68372 | Elastic fibres, collagen & muscle | SOP 68372 | Histopathology / Cytology |
| Endothelial tumours | CD31 | Endothelial tumours | CD31 | Histopathology / Cytology |
| Expressed in the female genital tract | PAX 8 | Expressed in the female genital tract | PAX 8 | Histopathology / Cytology |
| FFPE | FFPE kit | FFPE | FFPE kit | Histopathology / Cytology |
| FFPE | PP03.01.68 | FFPE | PP03.01.68 | Histopathology / Cytology |
| Ferric iron | Iron III Compounds – SOP 68371 | Ferric iron | Iron III Compounds – SOP 68371 | Histopathology / Cytology |
| Fresh tissue following: | Routine Surgical Trimming | Fresh tissue following: | Routine Surgical Trimming | Histopathology / Cytology |
| Frozen Tissue Lipids | Frozen Sections - SOP 68369 | Frozen Tissue Lipids | Frozen Sections - SOP 68369 | Histopathology / Cytology |
| Frozen Tissue | 68306. | Frozen Tissue | 68306. | Histopathology / Cytology |
| Frozen Tissue | CM1950 Cryostat – SOP 68296. | Frozen Tissue | CM1950 Cryostat – SOP 68296. | Histopathology / Cytology |
| Frozen Tissue | CM1950 Cryostat. | Frozen Tissue | CM1950 Cryostat. | Histopathology / Cytology |
| Frozen Tissue | Coldplate & Leica EG 1150 | Frozen Tissue | Coldplate & Leica EG 1150 | Histopathology / Cytology |
| Frozen Tissue | Cryomicrotomy: using the Leica | Frozen Tissue | Cryomicrotomy: using the Leica | Histopathology / Cytology |
| Frozen Tissue | Embedder. | Frozen Tissue | Embedder. | Histopathology / Cytology |
| Frozen Tissue | Embedding: using the Leica | Frozen Tissue | Embedding: using the Leica | Histopathology / Cytology |
| Frozen Tissue | External Document 1191. | Frozen Tissue | External Document 1191. | Histopathology / Cytology |
| Frozen Tissue | SOP 68386. | Frozen Tissue | SOP 68386. | Histopathology / Cytology |
| Frozen Tissue | Section Cutting – SOP 68294. | Frozen Tissue | Section Cutting – SOP 68294. | Histopathology / Cytology |
| Frozen Tissue | Slee Cut 4060 Microtomes. | Frozen Tissue | Slee Cut 4060 Microtomes. | Histopathology / Cytology |
| Frozen Tissue | Spectra Workstation – SOP 2220. | Frozen Tissue | Spectra Workstation – SOP 2220. | Histopathology / Cytology |
| Frozen Tissue | – SOP 68295. | Frozen Tissue | – SOP 68295. | Histopathology / Cytology |
| Fungi, neutral mucins /glycogen | Neutral Mucins - SOP 68355 | Fungi, neutral mucins /glycogen | Neutral Mucins - SOP 68355 | Histopathology / Cytology |
| Gastric neoplasms | CDX2 | Gastric neoplasms | CDX2 | Histopathology / Cytology |
| Glandular and transitional epithelia | CK7 | Glandular and transitional epithelia | CK7 | Histopathology / Cytology |
| Granulosa cell tumours | Inhibin | Granulosa cell tumours | Inhibin | Histopathology / Cytology |
| HPV related high grade cervical | P16 | HPV related high grade cervical | P16 | Histopathology / Cytology |
| High grade serous carcinomas of the | P53 | High grade serous carcinomas of the | P53 | Histopathology / Cytology |
| Identifying mantle cell lymphomas | Cyclin D1 | Identifying mantle cell lymphomas | Cyclin D1 | Histopathology / Cytology |
| Leucocytes | CD45 (LCA) | Leucocytes | CD45 (LCA) | Histopathology / Cytology |
| Malignant melanocytic tumours, | S100 | Malignant melanocytic tumours, | S100 | Histopathology / Cytology |
| Malignant melanoma | SOX-10 | Malignant melanoma | SOX-10 | Histopathology / Cytology |
| Melanocytes and melanomas | HMB45 | Melanocytes and melanomas | HMB45 | Histopathology / Cytology |
| Melanocytes, melanomas | Melan A | Melanocytes, melanomas | Melan A | Histopathology / Cytology |
| Mesothelioma, adenocarcinoma, | Calretinin | Mesothelioma, adenocarcinoma, | Calretinin | Histopathology / Cytology |
| Mismatch repair gene hMLH1 is a | MLH1 | Mismatch repair gene hMLH1 is a | MLH1 | Histopathology / Cytology |
| Molar pregnancy | P57 | Molar pregnancy | P57 | Histopathology / Cytology |
| MutS protein homolog 2 (MSH2) is | MSH2 | MutS protein homolog 2 (MSH2) is | MSH2 | Histopathology / Cytology |
| MutS protein homolog 6 (MSH6) is | MSH6 | MutS protein homolog 6 (MSH6) is | MSH6 | Histopathology / Cytology |
| Mycobacterium tuberculosis | Bacilli - SOP 68374 | Mycobacterium tuberculosis | Bacilli - SOP 68374 | Histopathology / Cytology |
| Neuroendocrine cells, NK cells | CD56 | Neuroendocrine cells, NK cells | CD56 | Histopathology / Cytology |
| Neutral & acid mucins / glycogen | Glycogen – SOP 1188 | Neutral & acid mucins / glycogen | Glycogen – SOP 1188 | Histopathology / Cytology |
| Non-neoplastic endometrial stroma. | CD10 | Non-neoplastic endometrial stroma. | CD10 | Histopathology / Cytology |
| Normal GI epithelia and urothelium | CK20 | Normal GI epithelia and urothelium | CK20 | Histopathology / Cytology |
| Normal and neoplastic lung and | TTF-1 | Normal and neoplastic lung and | TTF-1 | Histopathology / Cytology |
| Parvovirus infected cells | Parvovirus | Parvovirus infected cells | Parvovirus | Histopathology / Cytology |
| Postmeiotic segregation increased 2 | PMS2 | Postmeiotic segregation increased 2 | PMS2 | Histopathology / Cytology |
| Primary F/Tube high grade serous Ca, | WT1 | Primary F/Tube high grade serous Ca, | WT1 | Histopathology / Cytology |
| Products of Conception arising from: | (e.g) | Products of Conception arising from: | (e.g) | Histopathology / Cytology |
| Proliferative cells | Ki67 | Proliferative cells | Ki67 | Histopathology / Cytology |
| Renal cell carcinoma. Can also be | PAX 2 | Renal cell carcinoma. Can also be | PAX 2 | Histopathology / Cytology |
| Reticulin fibres | Reticulin Fibres - SOP 68358 | Reticulin fibres | Reticulin Fibres - SOP 68358 | Histopathology / Cytology |
| Rhabdomyosarcomas, leiomyomas, | Desmin | Rhabdomyosarcomas, leiomyomas, | Desmin | Histopathology / Cytology |
| Semen Post vasectomy: | Based on 2016 Laboratory | Semen Post vasectomy: | Based on 2016 Laboratory | Histopathology / Cytology |
| Smooth muscle tumours | Caldesmon | Smooth muscle tumours | Caldesmon | Histopathology / Cytology |
| Squamous differentiation in poorly | P63 | Squamous differentiation in poorly | P63 | Histopathology / Cytology |
| Squamous epithelium and neoplasms | Cytokeratin 5 | Squamous epithelium and neoplasms | Cytokeratin 5 | Histopathology / Cytology |
| Stem cells, melanocytes, mast cells, | CD117 | Stem cells, melanocytes, mast cells, | CD117 | Histopathology / Cytology |
| T-cells, NK cells, Thymocytes | CD68 | T-cells, NK cells, Thymocytes | CD68 | Histopathology / Cytology |
| Tissue epithelial in origin | AE1/AE3 | Tissue epithelial in origin | AE1/AE3 | Histopathology / Cytology |
| Tumor cell nuclei of | Myo D1 | Tumor cell nuclei of | Myo D1 | Histopathology / Cytology |
| Tumour cells in GIT carcinomas | CA19.9 | Tumour cells in GIT carcinomas | CA19.9 | Histopathology / Cytology |
| Vascular & lymphatic tumours | CD34 | Vascular & lymphatic tumours | CD34 | Histopathology / Cytology |
| Volume | Colorimetric strips | Volume | Colorimetric strips | Histopathology / Cytology |
| used in distinguishing ovarian serous | ‐ 2 | used in distinguishing ovarian serous | ‐ 2 | Histopathology / Cytology |
| Detection of antibodies adsorbed on | SOP 1565: ABO/ D group | Detection of antibodies adsorbed on | SOP 1565: ABO/ D group | Immunology / Serology |
| Detection of antibodies adsorbed on | SOP1527: ABO/ D group | Detection of antibodies adsorbed on | SOP1527: ABO/ D group | Immunology / Serology |
| EDTA Plasma Antibody Screen by detection of | Serascan 4 red cells. | EDTA Plasma Antibody Screen by detection of | Serascan 4 red cells. | Immunology / Serology |
| Bone Marrow | Reverse Transcription | Bone Marrow | Reverse Transcription | Molecular Diagnostics / PCR |
| CVS,Fixed Cells | PP 03.01.03, PP 03.01.04 | CVS,Fixed Cells | PP 03.01.03, PP 03.01.04 | Molecular Diagnostics / PCR |
| CVS,Fixed Cells | PP 03.01.11 | CVS,Fixed Cells | PP 03.01.11 | Molecular Diagnostics / PCR |
| Copy Number / Amplification | 01.01.97, Gl 01.01.06 | Copy Number / Amplification | 01.01.97, Gl 01.01.06 | Molecular Diagnostics / PCR |
| Copy Number / Amplification | FISH 01.01.04,FISH 01.01.95, FISH | Copy Number / Amplification | FISH 01.01.04,FISH 01.01.95, FISH | Molecular Diagnostics / PCR |
| DNA obtained from whole blood DYPD testing | PG 01.01.03 | DNA obtained from whole blood DYPD testing | PG 01.01.03 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in-house Determination of copy number | 3500XL. | Genomic DNA extracted in-house Determination of copy number | 3500XL. | Molecular Diagnostics / PCR |
| Genomic DNA extracted in-house Determination of copy number | PN 01.01.18 | Genomic DNA extracted in-house Determination of copy number | PN 01.01.18 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in-house Next Generation Sequencing of | 6000 and analysis using in-house | Genomic DNA extracted in-house Next Generation Sequencing of | 6000 and analysis using in-house | Molecular Diagnostics / PCR |
| Genomic DNA extracted in-house Next Generation Sequencing of | NGS using Nonacus Cell3 Target | Genomic DNA extracted in-house Next Generation Sequencing of | NGS using Nonacus Cell3 Target | Molecular Diagnostics / PCR |
| Genomic DNA extracted in-house Next Generation Whole Exome | Nonacus Cell3 Target ExomeCG | Genomic DNA extracted in-house Next Generation Whole Exome | Nonacus Cell3 Target ExomeCG | Molecular Diagnostics / PCR |
| Genomic DNA extracted in-house Post-transplant Chimaerism | 3500 XL. | Genomic DNA extracted in-house Post-transplant Chimaerism | 3500 XL. | Molecular Diagnostics / PCR |
| Genomic DNA extracted inhouse | Nanodrop 8000 | Genomic DNA extracted inhouse | Nanodrop 8000 | Molecular Diagnostics / PCR |
| Genomic DNA extracted inhouse | PP 03.01.27 | Genomic DNA extracted inhouse | PP 03.01.27 | Molecular Diagnostics / PCR |
| Genomic DNA extracted inhouse | PP 03.01.36 | Genomic DNA extracted inhouse | PP 03.01.36 | Molecular Diagnostics / PCR |
| Genomic DNA extracted inhouse | Qubit 2.0/4.0 fluorometer | Genomic DNA extracted inhouse | Qubit 2.0/4.0 fluorometer | Molecular Diagnostics / PCR |
| Insertions/deletions (indels) | BI 01.01.27 | Insertions/deletions (indels) | BI 01.01.27 | Molecular Diagnostics / PCR |
| Insertions/deletions (indels) | SC 01.02.14 | Insertions/deletions (indels) | SC 01.02.14 | Molecular Diagnostics / PCR |
| Insertions/deletions (indels) | SEQ 01.01.71 | Insertions/deletions (indels) | SEQ 01.01.71 | Molecular Diagnostics / PCR |
| Insertions/deletions (indels) | SEQ 01.01.73 | Insertions/deletions (indels) | SEQ 01.01.73 | Molecular Diagnostics / PCR |
| Insertions/deletions (indels), Copy | SEQ 01.01.76 | Insertions/deletions (indels), Copy | SEQ 01.01.76 | Molecular Diagnostics / PCR |
| Intra Genetic Fusions | HOA 01.01.40 | Intra Genetic Fusions | HOA 01.01.40 | Molecular Diagnostics / PCR |
| Intra Genetic Fusions | HOA 01.01.66 | Intra Genetic Fusions | HOA 01.01.66 | Molecular Diagnostics / PCR |
| Intra Genetic Fusions | SC 01.02.16 | Intra Genetic Fusions | SC 01.02.16 | Molecular Diagnostics / PCR |
| Intra Genetic Fusions | SC 01.02.23 | Intra Genetic Fusions | SC 01.02.23 | Molecular Diagnostics / PCR |
| Intra Genetic Fusions | SEQ 01.01.76 | Intra Genetic Fusions | SEQ 01.01.76 | Molecular Diagnostics / PCR |
| Number Variants (CNVs) | PN 01.01.42 | Number Variants (CNVs) | PN 01.01.42 | Molecular Diagnostics / PCR |
| Number Variants (CNVs) | RD 01.01.87 | Number Variants (CNVs) | RD 01.01.87 | Molecular Diagnostics / PCR |
| Number Variants (CNVs) | RD 01.01.88 | Number Variants (CNVs) | RD 01.01.88 | Molecular Diagnostics / PCR |
| Number Variants (CNVs) | SEQ 01.01.68 | Number Variants (CNVs) | SEQ 01.01.68 | Molecular Diagnostics / PCR |
| Number Variants (CNVs) | SEQ 01.01.71 | Number Variants (CNVs) | SEQ 01.01.71 | Molecular Diagnostics / PCR |
| Number Variants (CNVs), Inter and | SC 01.02.10 | Number Variants (CNVs), Inter and | SC 01.02.10 | Molecular Diagnostics / PCR |
| Plasma | SOPs: | Plasma | SOPs: MOL EXTR 015, 016 | Molecular Diagnostics / PCR |
| Prepared NGS libraries received Next Generation Sequencing of | 6000 | Prepared NGS libraries received Next Generation Sequencing of | 6000 | Molecular Diagnostics / PCR |
| RNA extracted inhouse from FFPE | PP 03.01.36 | RNA extracted inhouse from FFPE | PP 03.01.36 | Molecular Diagnostics / PCR |
| SNVs/indels | (Roche) | SNVs/indels | (Roche) | Molecular Diagnostics / PCR |
| SNVs/indels | Multiplex PCR (QIAgen) | SNVs/indels | Multiplex PCR (QIAgen) | Molecular Diagnostics / PCR |
| SNVs/indels | PN 01.02.03 | SNVs/indels | PN 01.02.03 | Molecular Diagnostics / PCR |
| SNVs/indels | PN 01.02.04 | SNVs/indels | PN 01.02.04 | Molecular Diagnostics / PCR |
| SNVs/indels | SOP:PN 01.02.10 | SNVs/indels | SOP:PN 01.02.10 | Molecular Diagnostics / PCR |
| Saliva (Oragene self collection kit) | PP.03.01.13 | Saliva (Oragene self collection kit) | PP.03.01.13 | Molecular Diagnostics / PCR |
| Variants (SVs) | BI 01.01.29 | Variants (SVs) | BI 01.01.29 | Molecular Diagnostics / PCR |
| Variants (SVs) | HOA 01.01.69 | Variants (SVs) | HOA 01.01.69 | Molecular Diagnostics / PCR |
| Variants (SVs) | HOA 01.01.71 | Variants (SVs) | HOA 01.01.71 | Molecular Diagnostics / PCR |
| Variants (SVs) | SEQ 01.01.71 | Variants (SVs) | SEQ 01.01.71 | Molecular Diagnostics / PCR |
| Variants (SVs) | SEQ 01.01.85 | Variants (SVs) | SEQ 01.01.85 | Molecular Diagnostics / PCR |
| [definitive list QA 01.02.60] | Analysis using integrated software | [definitive list QA 01.02.60] | Analysis using integrated software | Molecular Diagnostics / PCR |
| [definitive list QA 01.02.60] | BioRAD QX200 Droplet Reader | [definitive list QA 01.02.60] | BioRAD QX200 Droplet Reader | Molecular Diagnostics / PCR |
| [definitive list QA 01.02.60] | BioRAD AutoDroplet Generator | [definitive list QA 01.02.60] | BioRAD AutoDroplet Generator | Molecular Diagnostics / PCR |
| [definitive list QA 01.02.60] | BioRAD PCR Plate Reader | [definitive list QA 01.02.60] | BioRAD PCR Plate Reader | Molecular Diagnostics / PCR |
| [definitive list QA 01.02.60] | FRAG 01.01.10 | [definitive list QA 01.02.60] | FRAG 01.01.10 | Molecular Diagnostics / PCR |
| [definitive list QA 01.02.60] | Genemapper | [definitive list QA 01.02.60] | Genemapper | Molecular Diagnostics / PCR |
| [definitive list QA 01.02.60] | QPCR 01.01.01, QPCR 01.01.31 | [definitive list QA 01.02.60] | QPCR 01.01.01, QPCR 01.01.31 | Molecular Diagnostics / PCR |
| external sources repeat expansions, linkage makers, | FRAG 01.01.13 | external sources repeat expansions, linkage makers, | FRAG 01.01.13 | Molecular Diagnostics / PCR |
| from plasma aneuploidy (T13,18,21) | (NIPT) using | from plasma aneuploidy (T13,18,21) | (NIPT) using | Molecular Diagnostics / PCR |
| from plasma aneuploidy (T13,18,21) | LRM module for anlaysis. | from plasma aneuploidy (T13,18,21) | LRM module for anlaysis. | Molecular Diagnostics / PCR |
| from plasma aneuploidy (T13,18,21) | Library Preparation using Hamilton | from plasma aneuploidy (T13,18,21) | Library Preparation using Hamilton | Molecular Diagnostics / PCR |
| from plasma aneuploidy (T13,18,21) | Non-invasive Prenatal Testing | from plasma aneuploidy (T13,18,21) | Non-invasive Prenatal Testing | Molecular Diagnostics / PCR |
| from plasma aneuploidy (T13,18,21) | PN 01.01.43 | from plasma aneuploidy (T13,18,21) | PN 01.01.43 | Molecular Diagnostics / PCR |
| from plasma aneuploidy (T13,18,21) | Reporting of Lucina NIPT referrals | from plasma aneuploidy (T13,18,21) | Reporting of Lucina NIPT referrals | Molecular Diagnostics / PCR |
| from plasma aneuploidy (T13,18,21) | SEQ 01.01.69 NIPT Veriseq | from plasma aneuploidy (T13,18,21) | SEQ 01.01.69 NIPT Veriseq | Molecular Diagnostics / PCR |
| from plasma aneuploidy (T13,18,21) | Technical protocol | from plasma aneuploidy (T13,18,21) | Technical protocol | Molecular Diagnostics / PCR |
| prenatal diagnosis and pregnancy | 01.01.25, PN 01.01.38, HOA | prenatal diagnosis and pregnancy | 01.01.25, PN 01.01.38, HOA | Molecular Diagnostics / PCR |
| prenatal diagnosis and pregnancy | 01.01.55, HOA 01.01.26 | prenatal diagnosis and pregnancy | 01.01.55, HOA 01.01.26 | Molecular Diagnostics / PCR |
| prenatal diagnosis and pregnancy | ARRAY 01.01.45, DD 01.01.24, DD | prenatal diagnosis and pregnancy | ARRAY 01.01.45, DD 01.01.24, DD | Molecular Diagnostics / PCR |
| primary samples from external [definitive list QA 01.02.60] | Agarose gel electrophoresis | primary samples from external [definitive list QA 01.02.60] | Agarose gel electrophoresis | Molecular Diagnostics / PCR |
| primary samples from external [definitive list QA 01.02.60] | SOPs:TP 01.01.67 | primary samples from external [definitive list QA 01.02.60] | SOPs:TP 01.01.67 | Molecular Diagnostics / PCR |
| primary samples from external [definitive list QA 01.02.60] | TP 01.01.60 | primary samples from external [definitive list QA 01.02.60] | TP 01.01.60 | Molecular Diagnostics / PCR |
| primary samples from external [definitive list QA 01.02.60] | TP 01.01.61 | primary samples from external [definitive list QA 01.02.60] | TP 01.01.61 | Molecular Diagnostics / PCR |
| received as primary samples from | ABI 7500 Real time PCR system | received as primary samples from | ABI 7500 Real time PCR system | Molecular Diagnostics / PCR |
| received as primary samples from | HOA 01.01.57 | received as primary samples from | HOA 01.01.57 | Molecular Diagnostics / PCR |
| received as primary samples from | HOA 01.01.61 | received as primary samples from | HOA 01.01.61 | Molecular Diagnostics / PCR |
| received as primary samples from | QPCR 01.01.27 | received as primary samples from | QPCR 01.01.27 | Molecular Diagnostics / PCR |
| samples from external sources | PCR blocks, ABI 3730 Capillary | samples from external sources | PCR blocks, ABI 3730 Capillary | Molecular Diagnostics / PCR |
| samples from external sources | PP 03.01.35 | samples from external sources | PP 03.01.35 | Molecular Diagnostics / PCR |
| samples from external sources | SEQ 01.01.25 | samples from external sources | SEQ 01.01.25 | Molecular Diagnostics / PCR |
| sources | Agilent 2200 Tapestation, Qubit 2.0 | sources | Agilent 2200 Tapestation, Qubit 2.0 | Molecular Diagnostics / PCR |
| sources | BI 01.01.07: NIPD Bespoke | sources | BI 01.01.07: NIPD Bespoke | Molecular Diagnostics / PCR |
| sources | BI 01.01.08: NIPD RHDO | sources | BI 01.01.08: NIPD RHDO | Molecular Diagnostics / PCR |
| sources | Bioinformatics Pipeline | sources | Bioinformatics Pipeline | Molecular Diagnostics / PCR |
| sources | Fluorometer, thermal cycler and 2.0 | sources | Fluorometer, thermal cycler and 2.0 | Molecular Diagnostics / PCR |
| sources | SEQ 01.01.22 | sources | SEQ 01.01.22 | Molecular Diagnostics / PCR |
| sources | SEQ 01.01.71 | sources | SEQ 01.01.71 | Molecular Diagnostics / PCR |
| (preparative pre-examination steps | GL 01.01.19 | (preparative pre-examination steps | GL 01.01.19 | Other |
| (preparative pre-examination steps | HOA 01.01.05 | (preparative pre-examination steps | HOA 01.01.05 | Other |
| (preparative pre-examination steps | KARYO 01.01.06 | (preparative pre-examination steps | KARYO 01.01.06 | Other |
| (preparative pre-examination steps | PP 02.01.92 | (preparative pre-examination steps | PP 02.01.92 | Other |
| (preparative pre-examination steps | PP 02.01.93 | (preparative pre-examination steps | PP 02.01.93 | Other |
| (preparative pre-examination steps | PP 02.01.94 | (preparative pre-examination steps | PP 02.01.94 | Other |
| (preparative pre-examination steps | SOP TP 01.01.15 | (preparative pre-examination steps | SOP TP 01.01.15 | Other |
| AFs etc) | G-banding | AFs etc) | G-banding | Other |
| Acid mucins | Alcian Blue Method (pH2.5) for | Acid mucins | Alcian Blue Method (pH2.5) for | Other |
| Bone Marrow | SOP: PP 02.01.95 | Bone Marrow | SOP: PP 02.01.95 | Other |
| Bone Marrow | Separator | Bone Marrow | Separator | Other |
| Breast carcinoma (prinary & | GATA3 | Breast carcinoma (prinary & | GATA3 | Other |
| CVS check for subsequent in-house | Qiagen EZ1or EZ2 using EZ1&2 | CVS check for subsequent in-house | Qiagen EZ1or EZ2 using EZ1&2 | Other |
| Cancer cells (including | SATB2 | Cancer cells (including | SATB2 | Other |
| Cell-Free DNA extracted in-house CNV/(Rapid screening for | VeriSeq Solution v 2.0 | Cell-Free DNA extracted in-house CNV/(Rapid screening for | VeriSeq Solution v 2.0 | Other |
| Cultured Cells | PP 03.01.05 | Cultured Cells | PP 03.01.05 | Other |
| Detection of antibodies adsorbed on | SOP40: Manual methods for | Detection of antibodies adsorbed on | SOP40: Manual methods for | Other |
| EDTA Plasma Antibody Screen by detection of | SOP1527: ABO/D group, | EDTA Plasma Antibody Screen by detection of | SOP1527: ABO/D group, | Other |
| EDTA Plasma Antibody Screen by detection of | SOP40: Manual methods for | EDTA Plasma Antibody Screen by detection of | SOP40: Manual methods for | Other |
| Foetal Blood | PP 03.01.02 | Foetal Blood | PP 03.01.02 | Other |
| Fresh frozen solid tissue* | PP 03.01.07 | Fresh frozen solid tissue* | PP 03.01.07 | Other |
| Fresh frozen solid tissue* | Qiagen EZ1 or EZ2 using EZ1&2 | Fresh frozen solid tissue* | Qiagen EZ1 or EZ2 using EZ1&2 | Other |
| Frozen Tissue | 3003, Anglia Scientific AS300 and | Frozen Tissue | 3003, Anglia Scientific AS300 and | Other |
| Frozen Tissue | Microtomy | Frozen Tissue | Microtomy: using the PFM 3004 / | Other |
| Frozen Tissue | Sections) – SOP 68274. | Frozen Tissue | Sections) – SOP 68274. | Other |
| Fungi | Hexamine) - SOP 68360 | Fungi | Hexamine) - SOP 68360 | Other |
| Genomic DNA extracted in-house Next Generation Whole Exome | Illumina NovaSeq 6000 and | Genomic DNA extracted in-house Next Generation Whole Exome | Illumina NovaSeq 6000 and | Other |
| Insertions/deletions (indels) | SOPs: | Insertions/deletions (indels) | SOPs: | Other |
| Mouth Wash | PP 03.01.06 | Mouth Wash | PP 03.01.06 | Other |
| Number Variants (CNVs) | SOPs: | Number Variants (CNVs) | SOPs: | Other |
| O Rh D Negative | ABO/Rh (2D) + Kell card and | O Rh D Negative | ABO/Rh (2D) + Kell card and | Other |
| O Rh D Negative | SOP40: Manual methods for | O Rh D Negative | SOP40: Manual methods for | Other |
| POC | Manual DNA Extraction: | POC | Manual DNA Extraction: | Other |
| POC | PP 03.01.19 | POC | PP 03.01.19 | Other |
| POC | Precellys 24 Homogeniser | POC | Precellys 24 Homogeniser | Other |
| Plasma | PP 03.01.13 | Plasma | PP 03.01.13 | Other |
| Plasma | PP 03.01.21 | Plasma | PP 03.01.21 | Other |
| Plasma | PP 03.01.48 | Plasma | PP 03.01.48 | Other |
| Variants (SVs) | SOPs: | Variants (SVs) | SOPs: | Other |
| Whole Blood G-banding/Karyotyping: | Culturing and processing of | Whole Blood G-banding/Karyotyping: | Culturing and processing of | Other |
| [definitive list QA 01.02.60] | Analysis using GeneMarker and | [definitive list QA 01.02.60] | Analysis using GeneMarker and | Other |
| from an external source | PP 03.01.26: | from an external source | PP 03.01.26: | Other |
| from plasma aneuploidy (T13,18,21) | And | from plasma aneuploidy (T13,18,21) | And | Other |
| from plasma aneuploidy (T13,18,21) | Automated cfDNA extraction and | from plasma aneuploidy (T13,18,21) | Automated cfDNA extraction and | Other |
| from plasma aneuploidy (T13,18,21) | For | from plasma aneuploidy (T13,18,21) | For | Other |
| from plasma aneuploidy (T13,18,21) | Receipting, Processing and | from plasma aneuploidy (T13,18,21) | Receipting, Processing and | Other |
| from plasma aneuploidy (T13,18,21) | Star Liquid Handler and with | from plasma aneuploidy (T13,18,21) | Star Liquid Handler and with | Other |
| from plasma aneuploidy (T13,18,21) | With | from plasma aneuploidy (T13,18,21) | With | Other |
| primary samples from external [definitive list QA 01.02.60] | Using: | primary samples from external [definitive list QA 01.02.60] | Using: | Other |
| sources | Analysis using: | sources | Analysis using: | Other |
| specialist centres and long term | PP 03.01.08 | specialist centres and long term | PP 03.01.08 | Other |
| specialist centres and long term | PP 03.01.10: | specialist centres and long term | PP 03.01.10: | Other |
| specialist centres and long term | PP 03.01.14 | specialist centres and long term | PP 03.01.14 | Other |
| storage | PP 03.01.64 | storage | PP 03.01.64 | Other |
| used in distinguishing ovarian serous | ‐ 2 positive) | used in distinguishing ovarian serous | ‐ 2 positive) | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.